← Retour au Screener

Sector: Santé
Open in Terminal → AVNSLive chart · Key metrics · News · Smart money

Avanos Medical, Inc.

AVNS Small Cap

Healthcare · Medical Devices

Mis à jour: Jun 18, 2026, 22:21 UTC

21,74 €
+0.28% aujourd'hui
52W: 8,11 € – 22,22 €
52W Low: 8,11 € Position: 96.6% 52W High: 22,22 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
19.95x
P/E prévisionnel
P/S Ratio
1.63x
Cours/Ventes
EV/EBITDA
22.21x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
1,0 Md €
Capitalisation boursière
Croissance du CA
8.8%
Croissance du CA sur un an
Marge bénéficiaire
-10.39%
Marge nette
ROE
-9.18%
Rentabilité des capitaux propres
Beta
1.57
Sensibilité au marché
Positions vendeuses
3.32%
% du flottant vendu à découvert
Volume moyen
1,514,565
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
0 analysts

About the Company

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 2,287 Exchange: NYQ

Avanos Medical, Inc. en bref

Avanos Medical, Inc. (AVNS) is currently trading at 21,74 € with a market capitalization of 1,0 Md €. The 52-week range spans from 8,11 € to 22,22 €; the current price is 2.2% below the yearly high. Year-over-year revenue growth stands at +8.8%.

💰 Dividende

Avanos Medical, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

Avanos Medical, Inc. : la thèse d'investissement en détail

Avanos Medical, Inc. (AVNS) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

À surveiller

  • The share is trading at 96.6% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Points forts
  • Marge brute élevée de 50.05% — signe d'un pouvoir de fixation des prix
  • Bilan solide avec faible endettement (D/E 17.7)
  • Free cash flow positif
Points faibles
  • Actuellement non rentable
  • Cours proche du plus haut 52 semaines — faible marge de hausse

Aperçu technique

MM 50 jours
20,86 €
+4.22% vs. cours
MM 200 jours
13,34 €
+63.01% vs. cours
Sous le plus haut 52s
−2.2%
22,22 €
Au-dessus du plus bas 52s
+168.2%
8,11 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
1.57 · Élevé
Évolue plus que le marché global
Positions vendeuses
3.32% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
17.7 · Faible
Dette totale / capitaux propres

The data points to above-average price swings.

Trading Data

50-Day MA: 20,86 €
200-Day MA: 13,34 €
Volume: 2,544,004
Avg. Volume: 1,514,565
Short Ratio: 0.97
P/B Ratio: 1.49x
Debt/Equity: 17.7x
Free Cash Flow: 15 M €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Avanos Medical, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut